BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 36855960)

  • 21. Relationship between device-detected burden and duration of atrial fibrillation and risk of ischemic stroke.
    Al-Gibbawi M; Ayinde HO; Bhatia NK; El-Chami MF; Westerman SB; Leon AR; Shah AD; Patel AM; De Lurgio DB; Tompkins CM; Lloyd MS; Merchant FM; Kiani S
    Heart Rhythm; 2021 Mar; 18(3):338-346. PubMed ID: 33250442
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Refining Stroke Prediction in Atrial Fibrillation Patients by Addition of African-American Ethnicity to CHA2DS2-VASc Score.
    Kabra R; Girotra S; Vaughan Sarrazin M
    J Am Coll Cardiol; 2016 Aug; 68(5):461-470. PubMed ID: 27470453
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Atrial Fibrillation Burden Signature and Near-Term Prediction of Stroke: A Machine Learning Analysis.
    Han L; Askari M; Altman RB; Schmitt SK; Fan J; Bentley JP; Narayan SM; Turakhia MP
    Circ Cardiovasc Qual Outcomes; 2019 Oct; 12(10):e005595. PubMed ID: 31610712
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Validation of CHA2DS2 VASc Score Predictability of Stroke and Systemic Embolization in a Middle Eastern Population with AF: The Jordan Atrial Fibrillation (JoFib) Study.
    Ibdah R; Obeidat O; Khader Y; Al-Nusair J; Abusurrah O; Obeidat A; Obeidat A; Rawashdeh S; Alrabadi N; Obiedat AF; Alnadi NN; Hammoudeh A
    Vasc Health Risk Manag; 2023; 19():255-264. PubMed ID: 37125391
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The HAS-BLED score has better prediction accuracy for major bleeding than CHADS2 or CHA2DS2-VASc scores in anticoagulated patients with atrial fibrillation.
    Roldán V; Marín F; Manzano-Fernández S; Gallego P; Vílchez JA; Valdés M; Vicente V; Lip GY
    J Am Coll Cardiol; 2013 Dec; 62(23):2199-204. PubMed ID: 24055744
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Renal dysfunction, stroke risk scores (CHADS2, CHA2DS2-VASc, and R2CHADS2), and the risk of thromboembolic events after catheter ablation of atrial fibrillation: the Leipzig Heart Center AF Ablation Registry.
    Kornej J; Hindricks G; Kosiuk J; Arya A; Sommer P; Husser D; Rolf S; Richter S; Piorkowski C; Gaspar T; Lip GY; Bollmann A
    Circ Arrhythm Electrophysiol; 2013 Oct; 6(5):868-74. PubMed ID: 24047706
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High prevalence of atrial fibrillation among patients with ischemic stroke.
    Friberg L; Rosenqvist M; Lindgren A; Terént A; Norrving B; Asplund K
    Stroke; 2014 Sep; 45(9):2599-605. PubMed ID: 25034713
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Stroke risk in hypertrophic cardiomyopathy patients with atrial fibrillation: a nationwide database study.
    Hsu JC; Huang YT; Lin LY
    Aging (Albany NY); 2020 Nov; 12(23):24219-24227. PubMed ID: 33226371
    [TBL] [Abstract][Full Text] [Related]  

  • 29. First Diagnosis of Atrial Fibrillation at the Time of Stroke.
    Borowsky LH; Regan S; Chang Y; Ayres A; Greenberg SM; Singer DE
    Cerebrovasc Dis; 2017; 43(3-4):192-199. PubMed ID: 28208140
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The CHA
    Marzouka GR; Rivner H; Mehta V; Lopez J; Vaz I; Tang F; Ishwaran H; Goldberger JJ
    Am J Cardiol; 2021 Sep; 155():72-77. PubMed ID: 34274114
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relationship of Aging and Incident Comorbidities to Stroke Risk in Patients With Atrial Fibrillation.
    Chao TF; Lip GYH; Liu CJ; Lin YJ; Chang SL; Lo LW; Hu YF; Tuan TC; Liao JN; Chung FP; Chen TJ; Chen SA
    J Am Coll Cardiol; 2018 Jan; 71(2):122-132. PubMed ID: 29325634
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence, Characteristics, and Outcomes of Valvular Heart Disease in Patients With Atrial Fibrillation: Insights From the ORBIT-AF (Outcomes Registry for Better Informed Treatment for Atrial Fibrillation).
    Thomas KL; Jackson LR; Shrader P; Ansell J; Fonarow GC; Gersh B; Kowey PR; Mahaffey KW; Singer DE; Thomas L; Piccini JP; Peterson ED
    J Am Heart Assoc; 2017 Dec; 6(12):. PubMed ID: 29273635
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Practice Variation in Anticoagulation Prescription and Outcomes After Device-Detected Atrial Fibrillation.
    Perino AC; Fan J; Askari M; Heidenreich PA; Keung E; Raitt MH; Piccini JP; Ziegler PD; Turakhia MP
    Circulation; 2019 May; 139(22):2502-2512. PubMed ID: 30880434
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Estimated incidence of previously undetected atrial fibrillation on a 14-day continuous electrocardiographic monitor and associated risk of stroke.
    McIntyre WF; Wang J; Benz AP; Johnson L; Connolly SJ; Van Gelder IC; Lopes RD; Gold MR; Hohnloser SH; Lau CP; Israel CW; Wong JA; Conen D; Healey JS
    Europace; 2022 Jul; 24(7):1058-1064. PubMed ID: 35061877
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Echocardiography in newly diagnosed atrial fibrillation patients: a systematic review and economic evaluation.
    Simpson E; Stevenson M; Scope A; Poku E; Minton J; Evans P
    Health Technol Assess; 2013 Aug; 17(36):1-263, v-vi. PubMed ID: 23985296
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Usefulness of CHA
    Ording AG; Horváth-Puhó E; Prandoni P; Leisner MZ; Farkas DK; Steffensen FH; Olsen M; Sørensen HT; Schmidt M
    Am J Cardiol; 2019 Oct; 124(7):1059-1063. PubMed ID: 31376914
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Should atrial fibrillation patients with 1 additional risk factor of the CHA2DS2-VASc score (beyond sex) receive oral anticoagulation?
    Chao TF; Liu CJ; Wang KL; Lin YJ; Chang SL; Lo LW; Hu YF; Tuan TC; Chen TJ; Lip GY; Chen SA
    J Am Coll Cardiol; 2015 Feb; 65(7):635-42. PubMed ID: 25677422
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Optimising stroke prevention in patients with atrial fibrillation: application of the GRASP-AF audit tool in a UK general practice cohort.
    Shantsila E; Wolff A; Lip GY; Lane DA
    Br J Gen Pract; 2015 Jan; 65(630):e16-23. PubMed ID: 25548312
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Frequency of cardioversions as an additional risk factor for stroke in atrial fibrillation - the FinCV-4 study.
    Jaakkola S; Kiviniemi TO; Jaakkola J; Pouru JP; Nuotio I; Vasankari T; Hartikainen JEK; Airaksinen KEJ
    Ann Med; 2022 Dec; 54(1):1452-1458. PubMed ID: 35594342
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Does sex affect anticoagulant use for stroke prevention in nonvalvular atrial fibrillation? The prospective global anticoagulant registry in the FIELD-Atrial Fibrillation.
    Lip GY; Rushton-Smith SK; Goldhaber SZ; Fitzmaurice DA; Mantovani LG; Goto S; Haas S; Bassand JP; Camm AJ; Ambrosio G; Janský P; Al Mahmeed W; Oh S; van Eickels M; Raatikainen P; Steffel J; Oto A; Kayani G; Accetta G; Kakkar AK;
    Circ Cardiovasc Qual Outcomes; 2015 Mar; 8(2 Suppl 1):S12-20. PubMed ID: 25714828
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.